149 related articles for article (PubMed ID: 34085797)
1. Vaginal cancer as a late complication of radiotherapy for endometrial cancer and ileo-perineal fistula after total pelvic exenteration.
Comba C; Topaktas M; Bozkurt H; Erbin A; Ozdogan B; Demir O
J Gynecol Oncol; 2021 Jul; 32(4):e63. PubMed ID: 34085797
[TBL] [Abstract][Full Text] [Related]
2. Postoperative vaginal brachytherapy alone is the treatment of choice for grade 1-2, stage IC endometrial cancer.
Cengiz M; Singh AK; Grigsby PW
Int J Gynecol Cancer; 2005; 15(5):926-31. PubMed ID: 16174247
[TBL] [Abstract][Full Text] [Related]
3. Outcomes and toxicity after salvage radiotherapy for vaginal relapse of endometrial cancer.
Sapienza LG; Ning MS; de la Pena R; McNew LK; Jhingran A; Georgeon L; Rasool N; Gomes MJL; Abu-Isa E; Baiocchi G
Int J Gynecol Cancer; 2020 Oct; 30(10):1535-1541. PubMed ID: 32376738
[TBL] [Abstract][Full Text] [Related]
4. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
5. [Total pelvic exenteration in vaginal cancer--case report].
Olejek A; Arendt J; Olszak-Wasik K; Waniczek D; Zamłyński J; Horák S; Nowak L; Kozak-Darmas I
Ginekol Pol; 2013 Feb; 84(2):142-6. PubMed ID: 23668062
[TBL] [Abstract][Full Text] [Related]
6. Local recurrence in high-risk node-negative stage I endometrial carcinoma treated with postoperative vaginal vault brachytherapy.
Ng TY; Perrin LC; Nicklin JL; Cheuk R; Crandon AJ
Gynecol Oncol; 2000 Dec; 79(3):490-4. PubMed ID: 11104626
[TBL] [Abstract][Full Text] [Related]
7. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
[TBL] [Abstract][Full Text] [Related]
8. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma of the endometrium treated with combined irradiation and surgery: study of 437 patients.
Touboul E; Belkacémi Y; Buffat L; Deniaud-Alexandre E; Lefranc JP; Lhuillier P; Uzan S; Jannet D; Uzan M; Antoine M; Huart J; Ganansia V; Milliez J; Blondon J; Housset M; Schlienger M
Int J Radiat Oncol Biol Phys; 2001 May; 50(1):81-97. PubMed ID: 11316550
[TBL] [Abstract][Full Text] [Related]
10. Interstitial brachytherapy for salvage treatment of vaginal recurrences in previously unirradiated endometrial cancer patients.
Nag S; Yacoub S; Copeland LJ; Fowler JM
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):1153-9. PubMed ID: 12419443
[TBL] [Abstract][Full Text] [Related]
11. Outcome after salvage radiotherapy (brachytherapy +/- external) in patients with a vaginal recurrence from endometrial carcinomas.
Hasbini A; Haie-Meder C; Morice P; Chirat E; Duvillard P; Lhommé C; Delapierre M; Gerbaulet A
Radiother Oncol; 2002 Oct; 65(1):23-8. PubMed ID: 12413671
[TBL] [Abstract][Full Text] [Related]
12. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
Nout RA; Smit VT; Putter H; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; Mens JW; Slot A; Kroese MC; van Bunningen BN; Ansink AC; van Putten WL; Creutzberg CL;
Lancet; 2010 Mar; 375(9717):816-23. PubMed ID: 20206777
[TBL] [Abstract][Full Text] [Related]
13. Robotic type II B posterior exenteration for recurrent vaginal cancer.
Khadraoui W; Zeybek B; Mutlu L; Menderes G
Gynecol Oncol; 2019 Nov; 155(2):384-385. PubMed ID: 31345607
[TBL] [Abstract][Full Text] [Related]
14. [Total pelvic exenteration and rectal cancer. Apropos of 20 cases].
Lasser P; Doidy L; Elias D; Lusinchi A; Sabourin JC; Bonvalot S; Ducreux M
Chirurgie; 1999 Jun; 124(3):252-7. PubMed ID: 10429298
[TBL] [Abstract][Full Text] [Related]
15. Pelvic control following external beam radiation for surgical stage I endometrial adenocarcinoma.
Rush S; Gal D; Potters L; Bosworth J; Lovecchio J
Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):851-4. PubMed ID: 7591893
[TBL] [Abstract][Full Text] [Related]
16. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma: a prospective, randomized study--quality-of-life analysis.
Sorbe BG; Horvath G; Andersson H; Boman K; Lundgren C; Pettersson B
Int J Gynecol Cancer; 2012 Sep; 22(7):1281-8. PubMed ID: 22864336
[TBL] [Abstract][Full Text] [Related]
17. External beam radiotherapy versus vaginal brachytherapy in patients with stage II endometrial cancer: a systematic review and meta-analysis.
Narasimhulu DM; Cope A; Riaz IB; Petersen I; Cilby W; Langstraat C; Glaser G; Kumar A; Cappuccio S; Murad MH; West C; Mariani A
Int J Gynecol Cancer; 2020 Jun; 30(6):797-805. PubMed ID: 32221021
[TBL] [Abstract][Full Text] [Related]
18. Perineal template interstitial brachytherapy salvage for recurrent endometrial adenocarcinoma metastatic to the vagina.
Nag S; Martínez-Monge R; Copeland LJ; Vacarello L; Lewandowski GS
Gynecol Oncol; 1997 Jul; 66(1):16-9. PubMed ID: 9234914
[TBL] [Abstract][Full Text] [Related]
19. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
20. [The vaginal stump recurrence rate in endometrial carcinoma in relation to the target volume of postoperative HDR-afterloading brachytherapy].
Kloetzer KH; Günther R; Wendt T
Strahlenther Onkol; 1997 Jan; 173(1):13-7. PubMed ID: 9082580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
